What is Koate used for?
KOĀTE is indicated for the control and prevention of bleeding episodes. KOĀTE is indicated in order to perform emergency and elective surgery in patients with hemophilia A.
How is Kogenate administered?
Kogenate FS is administered by intravenous injection after reconstitution. Patients should follow the specific reconstitution and administration procedures provided by their physicians. Reconstitute and administer Kogenate FS with the components provided with each package.
Who makes koate?
Kedrion Biopharma has gained approval from the U.S. Food and Drug Administration to package Koate® Double Viral Inactivation (DVI) Antihemophilic Factor (human) with Mix2Vial™, a needle-free transfer device.
When was Eloctate FDA approved?
On Friday, June 6, 2014, the U.S. Food and Drug Administration approved Eloctate, Antihemophilic Factor (Recombinant), Fc fusion protein, for use in adults and children who have hemophilia A.
What does Eloctate treat?
This medication is used to control and prevent bleeding that happens to people (usually males) with an inherited medical condition, hemophilia A (low levels of factor VIII). It is also given before surgery to prevent too much bleeding in people with this condition.
How much does Kogenate cost?
The cost for Kogenate FS intravenous powder for injection recombinant is around $10 for a supply of 1 powder for injection, depending on the pharmacy you visit….Intravenous Powder For Injection.
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $10.16 | $10.16 |
How much does Kovaltry cost?
The cost for Kovaltry intravenous powder for injection recombinant is around $11 for a supply of 1 powder for injection, depending on the pharmacy you visit….Intravenous Powder For Injection.
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $11.42 | $11.42 |
What is Koate DVI used to treat?
Koāte-DVI is indicated for the treatment of classical hemophilia (hemophilia A) in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor VIII. Allergic-type reactions may result from the administration of Antihemophilic Factor (Human) preparations.
What is koāte ®?
KOĀTE® is a human plasma-derived antihemophilic factor indicated for the control and prevention of bleeding episodes or in order to perform emergency and elective surgery in patients with
What is kokoāte-DVI made from?
Koāte-DVI is made from human plasma. Products made from human plasma may contain infectious agents, such as viruses, and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent that can cause disease. There is also the possibility that unknown infectious agents may be present in such products.
What is the frequency of koāte administration?
• Frequency of KOĀTE administration is determined by the type of bleeding episode and the recommendation of the treating physician. KOĀTE is available as a lyophilized powder for reconstitution in single-use vials of 250, 500, and 1,000 international units of Factor VIII activity.